497
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Ofatumumab in the treatment of non-Hodgkin’s lymphomas

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Omid Rezahosseini, Sara Hanaei, Mehdi Hamadani, Mahsa Keshavarz-Fathi & Nima Rezaei. (2018) The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. International Reviews of Immunology 37:3, pages 165-173.
Read now

Articles from other publishers (10)

Rita Tavarozzi, Giulia Zacchi, Daniela Pietrasanta, Gioacchino Catania, Alessia Castellino, Federico Monaco, Carolina Gandolfo, Paolo Rivela, Antonella Sofia, Noemi Schiena, Claudia Bertassello, Giulia Limberti, Francesco Zallio, Manuela Zanni & Marco Ladetto. (2023) Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice. Cancers 15:22, pages 5397.
Crossref
Xueyan Chen, Qi Gao, Mikhail Roshal & Sindhu Cherian. (2023) Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy. Cytometry Part B: Clinical Cytometry 104:3, pages 205-223.
Crossref
Panagiotis Gklinos, Miranta Papadopoulou, Vid Stanulovic, Dimos D. Mitsikostas & Dimitrios Papadopoulos. (2021) Monoclonal Antibodies as Neurological Therapeutics. Pharmaceuticals 14:2, pages 92.
Crossref
Safa Shukry, Fadhel Hariri & Abdul Wahab Al-Nehmi. 2019. Advances in Hematologic Malignancies. Advances in Hematologic Malignancies.
Dario Didona, Roberto Maglie, Rüdiger Eming & Michael Hertl. (2019) Pemphigus: Current and Future Therapeutic Strategies. Frontiers in Immunology 10.
Crossref
Ming Sun & Han Zhang. (2019) Therapeutic antibodies for mantle cell lymphoma: A brand-new era ahead. Heliyon 5:3, pages e01297.
Crossref
Timothy M. Pierpont, Candice B. Limper & Kristy L. Richards. (2018) Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy. Frontiers in Oncology 8.
Crossref
Hidekazu Kawashima. 2018. Resistance to Ibritumomab in Lymphoma. Resistance to Ibritumomab in Lymphoma 79 97 .
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
W. Hiddemann, E. Hoster, C. Schmidt, M. Dreyling & M. Unterhalt. (2016) Aktuelle Therapiestrategien beim follikulären LymphomCurrent treatment strategies for follicular lymphoma. Der Internist 57:3, pages 222-229.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.